💊 GSK becomes, well, GSK; Otsuka says sayonara to Akebia; GII buys into Almeswak
A $25 million Legacy; HFMD on the rise in Malaysia
Hello there. How’s the week treating you so far? If you’re North Korean, probably not so well.
In today’s Kable: GSK rebrands, does it?; AZ doubles down on Covid antibodies; Eight Roads plots inroads in India; Apollo Global makes a big bet on biotech; Australia has a biotech blueprint; Monkeypox infections in the UK double; Dentists get AI, and nanobots…
Keep reading with a 7-day free trial
Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.